
P3 Health Partners Inc. Warrant
PIIIWCompany News
Wolf Haldenstein Adler Freeman & Herz LLP is investigating claims against P3 Health Partners, Inc. (PIII) for allegedly making false and misleading statements or omissions in violation of federal securities laws. The investigation is triggered by P3's disappointing financial results and a civil investigative demand from the Department of Justice.
Kuehn Law, a shareholder litigation law firm, is investigating potential self-dealing by officers and directors of P3 Health Partners Inc. (PIII). Shareholders may be entitled to damages and corporate governance reforms.
HENDERSON, Nev., March 07, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners, Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced the Company’s participation in the following investor conferences in March:



